Actively Recruiting
Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism
Led by Ester Ashraf Faried Beshay · Updated on 2025-12-01
100
Participants Needed
1
Research Sites
99 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
to detect the incidence of CTEPH patients. Primary outcome To predict CETHP in symptomatic patients after pulmonary embolism episode. Secondary outcome: On Echocardiography revealed RV dysfunction which are peak TR Velocity , the RV/LV basal diameter ratio, flattening of the IVS, RV acceleration time and/or midsystolic notching, IVC diameter with decreased inspiratory collapse and RA area.
CONDITIONS
Official Title
Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with acute pulmonary embolism
- Aged between 18 and 80 years old
- Pulmonary Embolism Severity Index (PESI) class III to V or sPESI score of 1 or higher
You will not qualify if you...
- Pulmonary hypertension caused by secondary conditions
- Severe kidney injury with eGFR above 30 mg/dl/1.7m2
- Liver disease
- Contraindications to anticoagulation therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Assiut University
Asyut, Egypt, AssiutU
Actively Recruiting
Research Team
E
Ester A Faried, resident
CONTACT
A
Aly M Tohamy, Professor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here